News

Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025
Detailed price information for Dare Bioscience Inc (DARE-Q) from The Globe and Mail including charting and trades.
Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the Bar
Detailed price information for Dare Bioscience Inc (DARE-Q) from The Globe and Mail including charting and trades.
Organon & Co. (OGN) Restructures, Expands in Women’s Health and Biosimilars
We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Organon & Co stands tenth on our list and has expanded in women’s health and biosimilars. Organon & Co. (NYSE:OGN), a global ...
Daré Bioscience, Inc.: Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY Sildenafil Cream
A first-of-its-kind solution for women's arousal in a proprietary topical formulation demonstrated to work where women need it most Targeted to be available by prescription in the fourth quarter of 20 ...
Finanznachrichten27d
Daré Bioscience, Inc.: Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for ...
The first FDA-approved product to emerge from Daré's portfolio of women's health product candidates is XACIATO (clindamycin phosphate) vaginal gel 2%, a lincosamide antibacterial indicated for the ...